F H Schroder
Overview
Explore the profile of F H Schroder including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
352
Citations
2882
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Heijnsdijk E, de Carvalho T, Auvinen A, Zappa M, Nelen V, Kwiatkowski M, et al.
J Natl Cancer Inst
. 2014 Dec;
107(1):366.
PMID: 25505238
Background: The results of the European Randomized Study of Screening for Prostate Cancer (ERSPC) trial showed a statistically significant 29% prostate cancer mortality reduction for the men screened in the...
2.
Wever E, Heijnsdijk E, Draisma G, Bangma C, Roobol M, Schroder F, et al.
Br J Cancer
. 2013 May;
108(10):1971-7.
PMID: 23674085
Background: Men with screen-detected prostate cancer can choose to undergo immediate curative treatment or enter into an expectant management programme. We quantified how the benefits and harms of immediate treatment...
3.
Roobol M, Schroder F, Hugosson J, Stephen Jones J, Kattan M, Klein E, et al.
World J Urol
. 2011 Dec;
30(2):149-55.
PMID: 22203238
Objectives: To compare the predictive performance and potential clinical usefulness of risk calculators of the European Randomized Study of Screening for Prostate Cancer (ERSPC RC) with and without information on...
4.
Otto S, van Leeuwen P, Hoekstra J, Merckelbach J, Blom J, Schroder F, et al.
Eur J Cancer
. 2010 Nov;
46(17):3061-7.
PMID: 21047587
Background: To assess the agreement between the causes of death assigned by a blinded and uniform review panel of the Rotterdam section of the European Randomised Study of Screening for...
5.
Gupta A, Roobol M, Savage C, Peltola M, Pettersson K, Scardino P, et al.
Br J Cancer
. 2010 Jul;
103(5):708-14.
PMID: 20664589
Background: Most men with elevated levels of prostate-specific antigen (PSA) do not have prostate cancer, leading to a large number of unnecessary biopsies. A statistical model based on a panel...
6.
Cremers R, Karim-Kos H, Houterman S, Verhoeven R, Schroder F, van der Kwast T, et al.
Eur J Cancer
. 2010 May;
46(11):2077-87.
PMID: 20471247
Background: Prostate cancer occurrence and stage distribution changed dramatically during the end of the 20th century. This study aimed to quantify and explain trends in incidence, stage distribution, survival and...
7.
Gosselaar C, Kranse R, Roobol M, Roemeling S, Schroder F
Prostate
. 2008 Apr;
68(9):985-93.
PMID: 18409186
Background: To analyze to what extent the percentage of suspicious digital rectal examination (DRE) findings vary between examiners and to what extent the percentage of prostate cancers (PCs) detected in...
8.
9.
Bangma C, Roemeling S, Schroder F
World J Urol
. 2007 Mar;
25(1):3-9.
PMID: 17364211
Early detection of prostate cancer is associated with the diagnosis of a considerable proportion of cancers that are indolent, and that will hardly ever become symptomatic during lifetime. Such overdiagnosis...
10.
Steyerberg E, Roobol M, Kattan M, van der Kwast T, de Koning H, Schroder F
J Urol
. 2006 Dec;
177(1):107-12.
PMID: 17162015
Purpose: Screening with serum prostate specific antigen testing leads to the detection of many prostate cancers early in their natural history. Statistical models have been proposed to predict indolent cancer....